Changsheng Bio-technology Co Ltd

002680

CNE100001DY7

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets
- ^CNY	-

2018	Changsheng Bio technology : China issues new delisting rules, to delist vaccine maker Changsheng	RE
2018	Hengli Indstrl Development : China's U-turn on market curbs brings back the speculators	RE

Changsheng Bio-Technology Proposes Final Cash Dividend for 2017

March 09, 2018 at 08:02 pm IST

The Changsheng Bio-Technology proposed final dividend of CNY 4.00000000 per 10 shares (tax included) for 2017.

Latest news about Changsheng Bio-technology Co Ltd

Changsheng Bio technology : China issues new delisting rules, to delist vaccine maker Changsheng	17/18/17	RE
Hengli Indstrl Development : China's U-turn on market curbs brings back the speculators	16/18/16	RE
Changsheng Bio technology : China sacks six senior officials at food and drug regulator over vaccine scandal	18/18/18	RE
Changsheng Bio-Technology Co., Ltd. Approves Cash Dividend for the Year 2017	11/18/11	CI
Changsheng Bio-Technology Proposes Final Cash Dividend for 2017	09/18/09	CI
Changchun Huapu Biotechnology Co., Ltd. announced that it expects to receive CNY 40 million in funding from Changsheng Bio-Technology Co., Ltd.	15/17/15	CI
Changsheng Bio-Technology Co., Ltd. Announces Cash Dividend, Payable on June 13, 2017	07/17/07	CI
Changsheng Bio-Technology Co., Ltd. Approves Cash Dividend for the Year 2016	26/17/26	CI
Changsheng Bio-Technology Co., Ltd. cancelled the acquisition of an additional 33.72% stake in Wuxi Sinosbio Biomedicine Science and Technology Co., Ltd. from Changchun Changsheng Life Sciences Limited on April 19, 2017.	19/17/19	CI
Changsheng Bio-Technology Co., Ltd Proposes Cash Dividend for the Year 2016	31/17/31	CI
Changsheng Bio-Technology Co., Ltd Announces 2015 Final Distribution Plan, Payable on 22 July 2016	18/16/18	CI
Changsheng Bio-Technology Co., Ltd Approves Cash Dividend for the Year 2015	30/16/30	CI
Changsheng Bio-Technology Co., Ltd. signed an agreement to acquire an additional 33.72% stake in Wuxi Sinosbio Biomedicine Science and Technology Co., Ltd. from Changchun Changsheng Life Sciences Limited for CNY 42.2 million.	20/16/20	CI
Lianyungang Huanghai Machinery Co., Ltd. has Changed its Name to Changsheng Bio-technology Co., Ltd	11/16/11	CI
Changchun Changsheng Life Sciences Limited announced that it expects to receive CNY 1.62 billion in funding from Lianyungang Huanghai Machinery Co., Ltd..	03/16/03	CI
Wuxi Sinosbio Biomedicine Science and Technology Co., Ltd. announced that it expects to receive CNY 20 million in funding from Changsheng Bio-Technology Co., Ltd.	03/16/03	CI
Changsheng Bio-Technology Co., Ltd. announced that it expects to receive CNY 1.659760776 billion in funding	20/16/20	CI
Zhang Minghao completed the acquisition of 10% stake in Lianyungang Huanghai Machinery Co., Ltd. from Liu Liangwen and Yu Chenpan.	24/15/24	CI
Changchun Changsheng Life Sciences Limited completed the acquisition of Lianyungang Huanghai Machinery Co., Ltd. in a reverse merger transaction.	15/15/15	CI
Shanghai Yaoyuan Investment Partnership (Limited Partnership) signed a stake transfer agreement to acquire 1.65% stake in Changchun Changsheng Life Sciences Limited from Yang Rui for CNY 42.5 million.	01/15/01	CI
Changchun Xiangsheng Investment Management Co., Ltd. signed a stake transfer agreement to acquire 4.87% stake in Changchun Changsheng Life Sciences Limited from Jin Jun for approximately CNY 130 million.	01/15/01	CI
Wuhu Zhuorui Innovation Investment Management Center (Limited Partnership) signed a stake transfer agreement to acquire 6.2% stake in Changchun Changsheng Life Sciences Limited from Ji Ning, Li Zhigang, Ju Shi and Wang Shiduo for approximately CNY 160 million.	01/15/01	CI
Wuhu Zhuorui Innovation Investment Management Center (Limited Partnership) signed a stake transfer agreement to acquire 1.35% stake in Changchun Changsheng Life Sciences Limited from Zhongguan Equity Investment Co., Ltd. for CNY 34.8 million.	01/15/01	CI
Wang Lining entered into an agreement to acquire 0.77% stake in Changchun Changsheng Life Sciences Limited from Wang Shiduo, Xu Lei, and Chen Gu for CNY 19.9 million.	01/15/01	CI
Wuhu Zhuorui Innovation Investment Management Center (Limited Partnership), Yang Hong, and Zhou Nanxin acquired 4.87% stake in Changchun Changsheng Life Sciences Limited from Huang Qili for approximately CNY 130 million.	01/15/01	CI

Chart Changsheng Bio-technology Co Ltd

Duration

Period

More charts

Changsheng Bio-technology Co., Ltd., formerly Lianyungang Huanghai Machinery Co., Ltd., is a China-based company principally engaged in the research, development, production and sale of human vaccine products. The Company's main products include live attenuated freeze-dried varicella vaccine, freeze-dried human rabies vaccine (Vero cells), freeze-dried live attenuated hepatitis A vaccine, influenza lysis vaccine, adsorption of cell-free diphtheria combined vaccine and ACYW Group 135 meningococcal polysaccharide vaccine. The Company distributes its products in domestic market and to overseas markets.

Sector

Pharmaceuticals

More about the company

Sector Biopharmaceuticals

	1st Jan change	Capi.
CHANGSHENG BIO-TECHNOLOGY CO LTD	0.00%	106M
CSL LIMITED	-2.26%	90.02B
SAMSUNG BIOLOGICS CO.,LTD.	-1.18%	39.15B
BIOGEN INC.	-15.83%	31.71B
UCB	+62.86%	26.47B
BIOMARIN PHARMACEUTICAL INC.	-21.68%	14.34B
INCYTE CORPORATION	-8.73%	12.89B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-15.05%	11.18B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-45.69%	10.97B
SWEDISH ORPHAN BIOVITRUM AB	+4.94%	8.94B

Biopharmaceuticals

Changsheng Bio-technology Co Ltd

Equities

002680

CNE100001DY7

Pharmaceuticals

Changsheng Bio-Technology Proposes Final Cash Dividend for 2017

Latest news about Changsheng Bio-technology Co Ltd

Chart Changsheng Bio-technology Co Ltd

Company Profile

Sector Biopharmaceuticals